The US Portfolio Strategy position is a 2-year medical affairs fellowship that ensures an integrated approach in aligning cross-tumor efforts throughout the medical organization. The fellow will be able to aid the Portfolio Strategy team in developing medical strategies for our marketed products as well as the assets in our pipeline, executing effective launches, and ensuring the safe and appropriate use of our medicines by healthcare providers and patients. This fellowship will provide a rotational experience in three key teams within the US Medical organization: Pan-Tumor Medical Strategy, Independent Medical Education (IME), and Oncology Research Strategy. During this program, the fellow will:
Engage in medical strategy tactics, including thought leader interactions, advisory board discussions, gathering field therapeutic area insights, and aligning with oncology medical partners on safety/patient management, dosing, and other cross-tumor topics.
Lead the strategic communication, collaboration, and awareness of cross-tumor efforts while partnering on execution with functional teams including US and Worldwide Medical, Clinical Development, Commercial, Publications, Medical Information, and Field Medical.
Participate in the execution of cross-tumor related deliverables including proactive patient management materials, medical proactive/reactive decks, and training materials for cross-matrix colleagues.
Create and lead the IME request for education (RFE) process for designated therapeutic areas of focus (strategy development), perform medical review and analysis of IME grant proposals, provide recommendations, and lead IME Review Committee meetings (tactical follow through on strategy). Additionally, review activity outcomes and present insights in knowledge and competence gains to the matrix teams.
Analyze outcomes data from BMS-supported medical education activities, communicate to the medical matrix teams for designated therapeutic areas of focus, and attend and audit continuing medical education programs supported by BMS.
Coordinate meetings with the field medical and home office medical teams to provide strategy updates and review potential investigator-sponsored research (ISR).
Support the US Medical organization in research priorities for emerging tumors and early assets.
Develop an understanding of the National Cancer Institute (NCI) Cooperative Groups and their important collaborative research with BMS.
Please consider attending Fellowship Information and Network Day here at Rutgers Ernest Mario School of Pharmacy on November 22nd from 3:30 PM – 8:00 PM so we can visit with you about your interests. For additional information please visit our website: http://pharmafellows.rutgers.edu/applicants/fid.php.
We do not pre-schedule interviews for Midyear, so please do not request an interview via this website. Your emails will not be reviewed.
We will be scheduling interviews starting at 10 AM on December 7th. Prior to scheduling an interview you will need to view the Fellowship information video
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, Universitywide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, email@example.com); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, firstname.lastname@example.org). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.